Horizon Therapeutics stock plunges on report FTC is preparing to block Amgen deal
Robert Galbraith | ReutersHorizon Therapeutics' stock plunged more than 17% in premarket trading Tuesday after a report that the Federal Trade Commission is preparing to file a lawsuit to block the biotech company's $27.8 billion sale to…